Patents by Inventor Jungu BAE

Jungu BAE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240325473
    Abstract: A pharmaceutical combination comprising (i) a replicative oncolytic vaccinia virus and (ii) an immune checkpoint protein inhibitor is provided as well as a kit comprising the pharmaceutical combination and methods for treating and/or preventing cancer.
    Type: Application
    Filed: June 10, 2024
    Publication date: October 3, 2024
    Applicant: SillaJen, Inc.
    Inventors: Chan KIM, Hongjae Jeon, Eun Sang Moon, Sungkuon Chi, Jiwon Sarah Choi, Joon-goo Jung, Jungu Bae
  • Publication number: 20240252563
    Abstract: A pharmaceutical combination comprising (i) a replicative oncolytic vaccinia virus and (ii) an immune checkpoint protein inhibitor is provided as well as a kit comprising the pharmaceutical combination and methods for treating and/or preventing cancer.
    Type: Application
    Filed: February 1, 2023
    Publication date: August 1, 2024
    Applicant: SillaJen, Inc.
    Inventors: Chan KIM, Hongjae JEON, Eun Sang MOON, Sungkuon CHI, Jiwon Sarah CHOI, Joon-goo JUNG, Jungu BAE
  • Publication number: 20200085891
    Abstract: A pharmaceutical combination comprising (i) a replicative oncolytic vaccinia virus and (ii) an immune checkpoint protein inhibitor is provided as well as a kit comprising the pharmaceutical combination and methods for treating and/or preventing cancer.
    Type: Application
    Filed: April 23, 2018
    Publication date: March 19, 2020
    Applicant: SillaJen, Inc
    Inventors: Chan KIM, Hongjae JEON, Eun Sang MOON, Sungkuon CHI, Jiwon Sarah CHOI, Joon-goo JUNG, Jungu BAE